Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 1757-1769
http://dx.doi.org/10.1351/pac200375111757
Estrogen receptor action through target genes with classical and alternative response elements
CrossRef Cited-by Linking
- Saxena Ruchi, Fatima Iram, Chandra Vishal, Blesson Chellakkan S., Kharkwal Geetika, Hussain Mohammad K., Hajela Kanchan, Roy Bal G., Dwivedi Anila: Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Steroids 2013, 78, 1071. <http://dx.doi.org/10.1016/j.steroids.2013.07.004>
- Chandra Vishal, Fatima Iram, Saxena Ruchi, Kitchlu Shakti, Sharma Sharad, Hussain Mohammad Kamil, Hajela Kanchan, Bajpai Preeti, Dwivedi Anila: Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus. Am J Obset Gynecol 2011, 205, 362.e1. <http://dx.doi.org/10.1016/j.ajog.2011.05.024>
- Hsia Elaine Y., Goodson Michael L., Zou June X., Privalsky Martin L., Chen Hong-Wu: Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Delivery Rev 2010, 62, 1227. <http://dx.doi.org/10.1016/j.addr.2010.09.016>
- Budhram-Mahadeo Vishwanie S, Latchman David S: Targeting Brn-3b in breast cancer therapy. eott 2006, 10, 15. <http://dx.doi.org/10.1517/14728222.10.1.15>
- Pearce Kenneth H., Iannone Marie A., Simmons Catherine A., Gray John G.: Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling. drug discov today 2004, 9, 741. <http://dx.doi.org/10.1016/S1359-6446(04)03201-5>